Introducing TheraCran™: the First and Only Cranberry Supplement Clinically Proven to Prevent Bacterial Adherence in the Urinary Tract
New consumer Website makes TheraCran™ available at www.TheraCran.com.
(PRWEB) September 22, 2006 -- Following a year-long development process with Ocean Spray International, Inc. and Dr. Amy Howell, of the world-renowned Phillip E. Marucci Blueberry and Cranberry Research Center of Rutgers University, Theralogix, LLC of Rockville, Maryland, has released TheraCran™ on a new consumer website.
Many published studies have demonstrated that the bioactive proanthocyanidins (PACs) found in cranberry products can prevent urinary tract infections (UTIs) by blocking the ability of bacteria to stick to the bladder lining. Now, a university-based clinical trial has confirmed that TheraCran™ produces significant levels of bacterial anti-adherence activity in the urine of human volunteers. TheraCran™ was introduced at the May 2006 American Urological Association (AUA) meeting, after TheraCran™ trial results were presented in April 2006 at the meeting of the Federation of American Societies for Experimental Biology and subsequently published in The FASEB Journal. Prior to today’s launch of the TheraCran™ consumer website, the urological community has been the primary source of referral for thousands of TheraCran™ customers.
About Urinary Tract Infections, Cranberry Juice, and Supplements
Urinary tract infections or “UTIs” are the most common bacterial infections in adults. According to the 1997 National Ambulatory Medical Care Survey, they are responsible for more than 8 million doctor office visits and almost a million visits to the emergency room each year.
Urinary tract infections are much more common in women then men, and one woman in three will have one by the age of 24. A recent study found that 11 percent of women surveyed reported having a UTI in the past year. After a single urinary tract infection, 30 to 50 percent of women will suffer a recurrence, most within a few months.
In the United States, over 11 million women receive antibiotics for a UTI each year. Repeated use of antibiotics will lead to resistant bacterial strains and an increased risk of recurrence. The U.S. health care system spends close to $2 billion per year dealing with urinary tract infections.
There is currently no scientifically-proven “natural cure” for a urinary tract infection (UTI). While various home remedies can provide symptom relief, only a prescription antibiotic can actually cure a UTI, bladder infection, or cystitis.
The daily dose of TheraCran™ (one capsule twice a day) delivers the PAC content of 12 ounces of cranberry juice, but more consistently and more effectively, at a lower cost, and with far fewer calories.
About Theralogix
Founded by a team of physicians and scientists in 2002, Theralogix sets the standard for evidence-based, independent third-party certified supplements, and has developed a full line of nutritional supplements recommended by physicians nationwide. Product development is guided by an 11-member Medical Advisory Board, which includes nationally known physicians and scientists in the fields of urology, gynecology, internal medicine, oncology, pharmacology and nutrition. All Theralogix products are independently tested and certified for content accuracy and purity through the non-profit NSF® International Dietary Supplements Certification Program.
Theralogix encourages customers to discuss nutritional supplementation with their health care providers who should monitor the efficacy of any non-prescription, all-natural treatment, and integrate it into a holistic health regimen.
The TheraCran consumer web site contains valuable educational and scientific resources as well as information about bladder health, and provides physician-approved guidance on safe, alternative, non-prescription techniques to prevent frequent or recurrent urinary tract infections. For more information, please visit http://www.theracran.com/faq.asp.
TheraCran™ is now available at www.theracran.com or toll-free at (800) 863-0062.
CONTACT INFORMATION:
Tiffany K. Graham, MPH, RD, LD
VP for Research and Education
Theralogix, LLC.
301-610-9940, ext. 3003
###
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/TWFnbi1FbXB0LUhvcnItSG9yci1JbnNlLVplcm8=
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
